A comparative investigation of contraceptive reliability, cycle control and tolerance of two monophasic oral contraceptives containing either drospirenone or desogestrel.
- 1 January 2000
- journal article
- clinical trial
- Published by Informa UK Limited in The European Journal of Contraception & Reproductive Health Care
- Vol. 5 (2), 124-134
- https://doi.org/10.1080/13625180008500387
Abstract
To assess the contraceptive reliability, cycle control and tolerance of a new monophasic oral contraceptive (Yasmin) containing 30 microg ethinylestradiol and 3 mg drospirenone and compare it with a preparation containing an equal dose of ethinylestradiol combined with 150 microg desogestrel (Marvelon).Keywords
This publication has 10 references indexed in Scilit:
- Inhibition of ovulation by a novel progestogen (drospirenone) alone or in combination with ethinylestradiol.The European Journal of Contraception & Reproductive Health Care, 2000
- Efficacy and tolerability of a monophasic oral contraceptive containing ethinylestradiol and drospirenoneThe European Journal of Contraception & Reproductive Health Care, 2000
- Women’s satisfaction with birth control: a population survey of physical and psychological effects of oral contraceptives, intrauterine devices, condoms, natural family planning, and sterilization among 1466 womenContraception, 1999
- Oral contraceptive discontinuation: A prospective evaluation of frequency and reasonsAmerican Journal of Obstetrics and Gynecology, 1998
- The novel progestin drospirenone and its natural counterpart progesterone: Biochemical profile and antiandrogenic potentialContraception, 1996
- Effects of estrogens and progestogens on the renin-aldosterone system and blood pressureSteroids, 1996
- Comparative Pharmacology of Newer ProgestogensDrugs, 1996
- Drospirenone: A novel progestogen with antimineralocorticoid and antiandrogenic activity: Pharmacological characterization in animal modelsContraception, 1995
- Dihydrospirorenone (ZK30595): A novel synthetic progestagen-characterization of binding to different receptor proteinsContraception, 1992
- Dihydrospirorenone, a New Progestogen with Antimineralocorticoid Activity: Effects on Ovulation, Electrolyte Excretion, and the Renin-Aldosterone System in Normal WomenJournal of Clinical Endocrinology & Metabolism, 1991